PSD-93 Antibodies

Santa Cruz Biotechnology features a diverse variety of PSD-93 monoclonal antibodies for research focused on understanding PSD-93's role in synaptic function and plasticity. PSD-93 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PSD-93, also known as DLG2, is a member of the membrane-associated guanylate kinase (MAGUK) family and plays a critical role in the organization of synaptic structures. PSD-93 is involved in the clustering of receptors and ion channels at the postsynaptic density, which is essential for synaptic signaling and plasticity. Research has shown that PSD-93 expression levels vary across different brain regions and developmental stages. Alterations in PSD-93 function have been linked to several neurological conditions, highlighting its importance in maintaining proper neural connectivity. Understanding PSD-93's molecular interactions and regulatory mechanisms can provide valuable insights into synaptic development and maintenance. Investigating PSD-93's role in receptor trafficking and synaptic organization may reveal new therapeutic approaches for neurological disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance the understanding of synaptic mechanisms and their implications in neurological health and disease.